feed,title,long_url,short_url
Benzinga,Legend Biotech-Janssen's Multiple Myeloma Cell Therapy Under Review In US,https://benzinga.com/general/biotech/21/05/21314752/legend-biotech-janssens-multiple-myeloma-cell-therapy-under-review-in-us,https://j.mp/2SyVVba
Benzinga,Zosano Stock Surges After New Study Shows Qtrypta's Potential As Long-Term Treatment Option For Migraine,https://benzinga.com/general/biotech/21/05/21314361/zosano-stock-surges-after-new-study-shows-qtryptas-potential-as-long-term-treatment-option-for-mi,https://j.mp/3oUC424
Benzinga,"The Daily Biotech Pulse: Vir-GlaxoSmithKline COVID-19 Antibody Treatment Approved, Zosano Spikes On Long-Term Migraine Drug Data, Decision Day For Eton, 2 IPOs",https://benzinga.com/general/biotech/21/05/21315499/the-daily-biotech-pulse-vir-glaxosmithkline-covid-19-antibody-treatment-approved-zosano-spikes-on,https://j.mp/3oZzM1F
